agilon health (NYSE:AGL) Sees Strong Trading Volume
Shares of agilon health, inc. (NYSE:AGL – Get Rating) saw an uptick in trading volume on Friday . 2,514,877 shares were traded during trading, a decline of 0% from the previous session’s volume of 2,526,085 shares. The stock last traded at $23.35 and had previously closed at $23.37.
Analysts Set New Price Targets
A number of brokerages recently weighed in on AGL. Wells Fargo & Company increased their price objective on shares of agilon health from $22.00 to $28.00 in a research report on Thursday, March 16th. Deutsche Bank Aktiengesellschaft increased their target price on agilon health from $26.00 to $28.00 in a report on Friday, March 3rd. Stifel Nicolaus initiated coverage on agilon health in a report on Thursday, December 8th. They issued a “buy” rating and a $23.00 target price on the stock. Finally, Guggenheim increased their target price on agilon health from $21.00 to $30.00 and gave the company a “buy” rating in a report on Monday, March 6th. One analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $29.38.
agilon health Stock Performance
The company has a market cap of $9.81 billion, a P/E ratio of -91.34 and a beta of 1.09. The business’s 50 day simple moving average is $23.48 and its 200 day simple moving average is $20.78. The company has a current ratio of 2.71, a quick ratio of 2.71 and a debt-to-equity ratio of 0.04.
Insiders Place Their Bets
In other agilon health news, insider Benjamin Kornitzer sold 8,094 shares of the firm’s stock in a transaction that occurred on Thursday, March 23rd. The shares were sold at an average price of $28.04, for a total transaction of $226,955.76. Following the sale, the insider now owns 55,426 shares in the company, valued at approximately $1,554,145.04. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other news, insider Benjamin Kornitzer sold 8,094 shares of agilon health stock in a transaction that occurred on Thursday, March 23rd. The shares were sold at an average price of $28.04, for a total transaction of $226,955.76. Following the sale, the insider now owns 55,426 shares in the company, valued at $1,554,145.04. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Benjamin Shaker sold 28,555 shares of agilon health stock in a transaction that occurred on Wednesday, February 15th. The shares were sold at an average price of $23.37, for a total transaction of $667,330.35. Following the sale, the insider now owns 25,625 shares in the company, valued at approximately $598,856.25. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 73,560 shares of company stock worth $1,651,339. Company insiders own 3.30% of the company’s stock.
Institutional Investors Weigh In On agilon health
Several large investors have recently made changes to their positions in the company. Amalgamated Bank increased its holdings in shares of agilon health by 1.1% in the fourth quarter. Amalgamated Bank now owns 42,827 shares of the company’s stock worth $691,000 after purchasing an additional 470 shares during the last quarter. Captrust Financial Advisors increased its stake in agilon health by 1.5% during the fourth quarter. Captrust Financial Advisors now owns 32,971 shares of the company’s stock worth $532,000 after acquiring an additional 487 shares during the last quarter. Synovus Financial Corp increased its stake in agilon health by 5.1% during the third quarter. Synovus Financial Corp now owns 10,671 shares of the company’s stock worth $251,000 after acquiring an additional 518 shares during the last quarter. Trexquant Investment LP increased its stake in agilon health by 1.2% during the third quarter. Trexquant Investment LP now owns 53,913 shares of the company’s stock worth $1,263,000 after acquiring an additional 657 shares during the last quarter. Finally, Xponance Inc. increased its stake in agilon health by 3.8% during the third quarter. Xponance Inc. now owns 21,509 shares of the company’s stock worth $504,000 after acquiring an additional 778 shares during the last quarter.
About agilon health
(Get Rating)
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
Featured Articles
Receive News & Ratings for agilon health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for agilon health and related companies with MarketBeat.com’s FREE daily email newsletter.
